Shuaa Rakan Alrwilli

Evaluation of Saudi Arabian Pharmacists' Awareness and Expertise about Ledipasvir Sofosbuvir

Shuaa Rakan Alrwilli · Journal of Pharmaceutical Research International · 2024

Introduction: Ledipasvir/sofosbuvir is a fixed-dose combination of two antiviral drugs with different mechanisms of action. It is used to treat chronic hepatitis C genotype 1 infection in adults as a fixed-dose combination tablet containing 90 mg ledipasvir and 400 mg sofosbuvir....

Open access Research Article 10.9734/jpri/2024/v36i127638

Alpelisib Efficacy in Advanced Breast Cancer

Hani Raka Karrar, Mahmoud Ismail Nouh, Amnah Alhassan Alnami, Bashayr Eid Alrasheedi, Shuaa Rakan Alrwilli, Najwa Ahmed Hussain Durbashi, Lujain Badr Baghlaf, Ahmed Jamaan AlGhamdi, Zakaria Y. Otayn, Waad Fareed H Aowaiwi, Khalid Saad S Alghamdi, Alwaleed Oudah Hamdan Aljohani & Abdulrahman Saeed A Alzahrani · Journal of Pharmaceutical Research International · 2023

Breast cancer is one of the popular problems related to the medical field. Breast cancer become more aggressive, and the incidence rate keeps increasing yearly. The incidence indicates the slow progression of the disease. Yearly, there are more than one million new cases that get...

Open access Research Article 10.9734/jpri/2023/v35i357485